anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
A method includes for non-invasively determining an instantaneous wave-free ratio metric includes receiving electronically formatted image data generated by an imaging system. The image data includes voxels with intensities representative of a vessel with a stenosis. The method further includes computing peripheral resistances of outlets of the vessel from the image data. The method further includes calculating a stenosis resistance of the stenosis between an inlet of the vessel inlet and the outlets of the vessel based on a set of boundary conditions and a computational fluid dynamics algorithm. The method further includes calculating the instantaneous wave-free ratio metric. The metric is a numerical value, based on the stenosis resistance and generating a signal indicative of the calculated instantaneous wave-free ratio metric.
The pathophysiology behind the breathlessness and fatigue experienced by CHF patients during exercise remains unclear. Recent evidence suggests that the peripheral skeletal muscle, which becomes abnormal in heart failure, is the source of afferent signals which disrupt normal patterns of cardiorespiratory control. When CHF patients exercise, an inappropriately strong sympathetic response further limits exercise tolerance by evoking larger than normal increases in peripheral sympathetic activation at a faster rate than in healthy individuals. A consequence of this exacerbated sympathetic response may be the further sympathetic restraint of blood flow to the active skeletal muscles resulting in hypoperfusion of the muscle vascular bed and fatigue. Small muscle mass exercise training increases muscle oxidative capacity and improves aerobic work capacity in CHF patients. A range of studies is proposed here that will provide an integrative view of the mechanistic basis behind exercise intolerance in CHF and relate the intramuscular metabolic status to the autonomic control of hemodynamics during exercise. An understanding of the mechanistic basis of the improved exercise tolerance with training, independent of improved resting cardiac function, will yield important information regarding the integrated control of blood flow and metabolic demand in CHF and highlight the importance of maintaining the integrity of the peripheral musculature in CHF.
Upon finding skeletal unidentified remains, four are the questions that must be answered: age, sex, ancestry, and stature. Regarding age estimation, clavicle has received special attention because medial epiphysis is the last epiphysis, among long bones that ossifies. Falys and Prangle proposed a method of age estimation based on three degenerative characteristics-surface topography (TOP), Porosity (POR) and Osteophyte formation (OST)-evaluated on the sternal end of the clavicle according to the descriptions and the illustrations provided in the original article producing satisfactory results. The current study aims to test the applicability of the Falys' and Prangle's method on 174 individuals from two contemporary samples, one from Greece (Cretan osteological Collection and Athens Forensic Anthropology Lab collection) and one from Thailand (Osteological collection in Chiang Mai). Composite scores were calculated, inter and intra- observer error were estimated by kappa statistics and regression equations of the original study were tested in our sample and in subsamples divided by sex and population. The Greek sample gave more accurate estimates compared to the Thai sample. Regressions of known sex gave slightly better results in most cases. When individuals <40 years old were excluded, classification increased for both Thai and Greeks. The results of this pilot study indicate that there are morphological features on the clavicle that are highly correlated with age. Thus, there is a scope of expanding research on the morphological features of the collar bone.
1502902 Yeast extracts BAYER AG 13 Oct 1975 [5 Nov 1974 7 May 1975 12 Aug 1975] 41822/75 Heading A5B [Also in Divisions C3 and C6] Therapeutic products exhibiting tumourinhibiting activities are obtained by subjecting a material containing or derived from yeast cell walls to extraction with phenol-water and recovering the product from the aqueous phase of the extraction. The material extracted may be (1) complete yeast cells, or a proteolytic (trypsin) or autolytic digest of the cells ("zymosan"); (2) yeast cell walls, or a proteolytic (trypsin) degradation product thereof ("yeast cell wall zymosan") or (3) glucomannon or glucan protein derived from the yeast cell walls. The material may have been derived from yeast of the species Saccharomyces cerevisiae or Candida utilis. Freeze-dried baker's yeast may be used. The material is typically extracted with 10 to 100 parts per part of material of an equal mixture of phenol and water by volume at a temperature of from 40 to 100‹C for 10-30 minutes. The therapeutic product is recovered by dialysis of the aqueous phase followed by lyophilisation of the retentate (sediment and/ or supernatant liquor) obtained by the dialysis. The product may be made up into tablets, &c. in unit dosage form or otherwise. Pharmaceutical compositions may be prepared containing 0.5-95% by weight of the product. Suitable adjuvants (conventional) for such medicaments and pharmaceutical compositions are set forth in detail. Examples 16 and 20 describe the preparation from yeast cell wall of glucomannon proteins I and II.
A system and method for the parenteral delivery of a drug in a biodegradable polymeric matrix to a warm blooded animal as an aqueous liquid with the resultant formation of a hydrogel depot for the controlled release of the drug. The system comprises an injectable biodegradable block copolymeric drug delivery liquid having thermal gelation properties. The copolymer has a gel/sol transition temperature such that, above the body temperature of the animal to which it is administered, it is a solution and when administered and cooled to body temperature it forms a hydrogel. The copolymer is made up of (i) a hydrophobic A polymer block of poly (.alpha.-hydroxy acid) and (ii) a hydrophilic B polymer block comprising a poly(ethylene oxide). The drug is released at a controlled rate from the copolymer which biodegrades into non-toxic products. The gel/sol transition temperature and degradation rate can be adjusted by proper selection of the molecular weight and concentration of the poly (.alpha.-hydroxy acid) and poly(ethylene oxide) polymer block components.
The invention relates to a pharmaceutical composition for treating Hashimoto's thyroiditis and a preparation method thereof. The pharmaceutical composition is composed of bupleurum, radix curcumae, prunella vulgaris, rhizoma Dioscoreae Nipponicae, thunberg fritillary bulb, radix scrophulariae, edible tulip, astragalus, dark plum and other components, and can be made into granules, capsules, tablets or pills by the conventional pharmaceutical processes. The pharmaceutical composition has the effects of soothing liver-qi stagnation, reducing phlegm, removing stasis, and softening hardness to dissipate stagnation, and applies to patients with Hashimoto's thyroiditis and thyroid nodules. Clinical studies have shown that the pharmaceutical composition can significantly improve the symptoms of Hashimoto's thyroiditis, reduce the thyroid volume and isthmus thickness, and reduce the level of TgAb and TPOAb, and the total effective rate is 97.22%. In addition, for patients with thyroid nodules, nodules can be significantly reduced or even disappeare, no significant adverse reactions are presented in the course of treatment. Experimental studies have shown that the pharmaceutical composition reduces the level of TgAb and TPOAb, and reduces inflammatory infiltration and thyroid follicular damage.
This group will consist of 25 participants. Initially, the protocol of exercises performed in the therapeutic exercise group will be applied. In sequence, the interferential current will be applied. Through the Endophasys® device - NMS-0501, KLD Biosistemas® Equipamentos Eletrônicos Ltda). Four electrodes (8x5 cm), two upper and two lower (forming a square) will be positioned around the center of the neck. The electrodes will be positioned crosswise, following the parameters: 4KHz (carrier frequency), 1/1 second (Sweep Mode), 60 Hz Amplitude of frequency modulation (AMF), 30 Hz (Delta AMF), automatic vector mode, with intensity at the motor threshold of sensation, lasting 30 minutes (Albornoz-Cabello et al., 2019).
ATP1A2 encodes a subunit of sodium/potassium-transporting adenosine triphosphatase (Na+ /K+ -ATPase). Heterozygous pathogenic variants of ATP1A2 cause familial hemiplegic migraine, alternating hemiplegia of childhood, and developmental and epileptic encephalopathy. Biallelic loss-of-function variants in ATP1A2 lead to fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies, resulting in fetal death. Here, we describe a patient with compound heterozygous ATP1A2 variants consisting of missense and nonsense variants. He survived after birth with brain malformations and the fetal akinesia/hypokinesia sequence. We report a novel type of compound heterozygous variant that might extend the disease spectrum of ATP1A2.
1. Recognition of labrum images based on LeNet: axial and oblique coronal T2-fs images were used, and all images were corrected and standardized. LeNet identified the images with labrum of the shoulder joint, and the images with labrum structure of shoulder joint were selected from the complete sequence. In contrast, the images without labrum structure were deleted. All the data are divided into a training set (70%, 30% in training set as verification set), and the remaining 30% as a test set to evaluate the accuracy of model recognition. Enter the obtained results into the next step.
2. Recognition and segmentation of glenoid lip of shoulder joint based on DenseNet: the labrum is recognized by DenseNet in the selected image. The labelimg software based on Python was used to locate the labrum coordinates and then input them into Python for recognition learning. All the data were divided into a training set (70% and 30% of the training set were selected as the verification set). The remaining 30% was used as the test set to evaluate the accuracy of model recognition. After identifying the labrum structure, the labrum structure is locally cut and enlarged to remove the redundant information and improve the recognition efficiency and accuracy. Finally, input the result to the next step.
3. Recognition and grading of shoulder SLAP injury based on 3D-CNN: recognition and grading of input data through 3D-CNN model. 3D-CNN is divided into eight layers: input layer, hard wire layer H1, convolution layer C2, downsampling layer S3, convolution layer C4, downsampling layer S5, convolution layer C6 and output layer. 3D-CNN constructs a cube by stacking multiple consecutive frames and then uses a 3D convolution kernel in the cube. Through this structure, the feature images in the convolution layer will be connected with multiple adjacent frames in the previous layer to realize the information acquisition of continuous images. Similarly, the data is divided into a training set (70%, and then 30% of the training set is selected as the verification set), and the remaining 30% is used as the test set to evaluate the classification accuracy to identify whether there is labrum injury and grade the image with injury.
4. Establish CNN combined model: after establishing the model for the axial and oblique coronal view according to the above process (1-3), according to the output characteristics of the CNN classification model, predict the probability of different grades before the output results, and the output results are based on these probabilities to select the expression form of the maximum possible probability. Our combined model averages the probabilities of these different classifications, calculates the final prediction probability, and then obtains the final joint model. The test set of the third step (including the mixed data of axial and coronal images) was used to verify the joint model.
The use of herbal medicines in the treatment of various medical and psychiatric conditions has accelerated in the last decade. It has also become evident that herbal medications are being used concomitantly with conventional prescription and over-the-counter medications. However, the systematic evaluation of the potential of these agents to interact with conventional medications has been generally neglected. Compounding this problem is the fact that even single entity herbal products can contain a multitude of naturally occurring chemicals which serve as candidates for potential herb-drug interactions by inhibiting or inducing specific hepatic isozymes. Numerous reports document the importance of pharmacokinetic interactions involving inhibition or induction of the cytochrome P450 (CYP) enzyme system. In this study, the ten most commonly used herbal products in the US will be systematically evaluated for inhibition of CYP 3A4 and 2136, and induction of CYP 3A4. Collectively, these enzyme systems are involved in the metabolism of approximately 80% of all marketed medications.

Participants in this study will receive a single dose of the prescription drug alprazolam and the over-the-counter cough suppressant, dextromethorphan on two occasions. A combination of probe drugs will be given to normal volunteers both in the absence and presence of herbal medications. The plasma and urine concentration of these agents and their respective metabolites will be determined in order to evaluate individual herbal products degree and specificity of enzyme inhibitory or inductive effects.
Safety and effectiveness of ZORCAINE in pediatric patients below the age of 4 years have not been established. Safety of doses greater than 7 mg/kg (0.175 mL/kg) in pediatric patients has not been established.  
The safety and effectiveness of ZORCAINE for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures have been established in pediatric patients ages 4 to 16 years old. Safety and effectiveness was established in clinical trials with 61 pediatric patients between the ages of 4 and 16 years administered articaine hydrochloride 4% and epinephrine 1:100,000 injections. Fifty-one of these patients received doses from 0.76 mg/kg to 5.65 mg/kg (0.9 to 5.1 mL) for simple dental procedures and 10 patients received doses between 0.37 mg/kg and 7.48 mg/kg (0.7 to 3.9 mL) for complex dental procedures. Approximately 13% of these pediatric patients required additional injections of anesthetic for complete anesthesia. Dosages in pediatric patients should be reduced, commensurate with age, body weight, and physical condition [see Dosage and Administration (2.2)].
PURPOSE:To prepare a polypeptide having diuretic action, economically, by transforming a microorganism with a plasmid integrated with a novel gene coding a polypeptide produced by the atrium of rat and having diuretic activity, and culturing the transformed microorganism. CONSTITUTION:A plasmid containing the base sequence coding a polypeptide produced by the rat atrium and having diuretic activity and the base sequence participating in the manifestation of the above base sequence, is prepared beforehand. A microorganism (e.g. Escherichia coli) or an animal cell is transformed with the plasmid. The transformed microorganism or animal cell is cultured in a medium to produce and accumulate the polypeptide having diuretic activity. The objective physiologically active peptide consisting of 126 amino acids and having diuretic and hypotensive activities can be prepared by separating and purifying the polypeptide accumulated in the culture product.
The regulatory role of the inhibitor of NF-kB kinase ε (IKKε) in postmyocardial infarction (MI) inflammation remains uncertain. Using an MI mouse model, we examined the cardiac outcomes of IKKε knockout (KO) mice and wild-type mice. We employed single-cell RNA sequencing (scRNA-seq) and phosphorylated protein array techniques to profile cardiac macrophages. IKKε KO mice exhibited compromised survival, heightened inflammation, pronounced cardiac fibrosis, and a reduced ejection fraction. A distinct cardiac macrophage subset in IKKε KO mice exhibited increased fibrotic marker expression and decreased phosphorylated p38 (p-p38) levels, indicating an enhanced macrophage-myofibroblast transition (MMT) post-MI. While cardiac inflammation is crucial for initiating compensatory pathways, the timely resolution of inflammation was impaired in the IKKε KO group, while the MMT in macrophages accelerated post-MI, leading to cardiac failure. Additionally, our study highlighted the potential of 5-azacytidine (5-Aza), known for its anti-inflammatory and cardioprotective effects, in restoring p-p38 levels in stimulated macrophages. The administration of 5-Aza significantly reduced the MMT in cardiac macrophages from the IKKε KO group. These findings underscore the regulation of the inflammatory response and macrophage transition by the IKKε-p38 axis, indicating that the MMT is a promising therapeutic target for ischemic heart disease.
S: maintain anesthesia with Sevorane® (Sevoflurane) at 2%. Volatile concentration was titrated according to end-tidal MAC to maintain 0.7-1.3 MAC using end-tidal monitor of Dräger Primus anesthesia machine.
The safety and tolerability of CyPep-1 at RP2D will be further evaluated with focus on assessing efficacy signals of CyPep-1 monotherapy in subjects with melanoma. CyPep-1 administration is planned as QW injections until the second iRECIST/itRECIST assessment at week 16, followed by a Q2W dosing scheme.
Lower limb assistive robotic devices, such as active prosthesis, orthoses, and exoskeletons have the potential to restore function for the millions of Americans who experience mobility challenges due to injury and disability. Since individuals with mobility challenges have an increased metabolic costs of transport, the benefit of such assistive devices is commonly assessed via the reduction in the metabolic work rate of the individual who is using the device. Currently, metabolic work rate can only be obtained in a laboratory environment, using breath-by-breath measurements of respiratory gas analysis. To obtain a single steady state data point of metabolic work rate, multiple minutes of data must be collected, since the signals are noisy and slow. In addition, the user has to wear a mask and bulky equipment. The investigators propose an improved way to obtain such estimates of metabolic work rate in real-time. In this project, the investigators will use various small sensors to optimize push-off timing for an active ankle prosthesis.
Diet composition impacts metabolic health and is now recognized to shape the immune system, especially in the intestinal tract. Nutritional imbalance and increased caloric intake are induced by high-fat diet (HFD) in which lipids are enriched at the expense of dietary fibers. Such nutritional challenge alters glucose homeostasis as well as intestinal immunity. Here, we observed that short-term HFD induced dysbiosis, glucose intolerance and decreased intestinal RORγt+ CD4 T cells, including peripherally-induced Tregs and IL17-producing (Th17) T cells. However, supplementation of HFD-fed male mice with the fermentable dietary fiber fructooligosaccharides (FOS) was sufficient to maintain RORγt+ CD4 T cell subsets and microbial species known to induce them, alongside having a beneficial impact on glucose tolerance. FOS-mediated normalization of Th17 cells and amelioration of glucose handling required the cDC2 dendritic cell subset in HFD-fed animals, while IL-17 neutralization limited FOS impact on glucose tolerance. Overall, we uncover a pivotal role of cDC2 in the control of the immune and metabolic effects of FOS in the context of HFD feeding.
This is the first controlled acute treatment study of bipolar disorder in adults 60 years or older with current DSM-IV manic, mixed, or hypomanic episodes. The number of older adults with severe and disabling bipolar disorder is increasing, and information to guide the management of the treatment of the disease is lacking in this population. Guidelines for treatment of younger people with bipolar disorder cannot be used for older people, and there are no safety and efficacy data upon which to base initial treatment decisions for older patients with bipolar mania. Mood stabilizers (lithium and divalproex) are the first-line treatment for bipolar disorder. However, in aged patients physiological changes and comorbid diseases may increase vulnerability to side effects and limit the benefits of the medications.

This double-blind study will compare the benefits and side-effects of 9 weeks of treatment with lithium and divalproex in people with bipolar mania. Participants, who may be treated during inpatient hospitalization or as outpatients, will be randomly assigned to receive either lithium or divalproex. During the first 3 weeks of treatment careful titration of lithium and divalproex will be done to reach dose ranges. All other psychotropic medications will be discontinued. Behavioral interventions and/or lorazepam may be added, if necessary. After the first 3 weeks, if symptoms do not improve, risperidone will be added to be taken everyday with the study medication.
Provided are superabsorbent materials composed of agar, and one or more water-soluble natural polysaccharides, and dietary compositions containing such superabsorbent materials. The disclosed superabsorbent materials have various food and therapeutic applications and can be used as loading vehicles for nutrients and therapeutic agents. Also provided are methods for preparing such superabsorbent materials.Provided are superabsorbent materials composed of agar, and one or more water-soluble natural polysaccharides, and dietary compositions containing such superabsorbent materials. The disclosed superabsorbent materials have various food and therapeutic applications and can be used as loading vehicles for nutrients and therapeutic agents. Also provided are methods for preparing such superabsorbent materials. Disclosed herein are programmable, conditionally activated small interfering RNA constructs (Cond-siRNAs) and methods of making and using the same as therapeutic agents. The Cond-siRNA comprises a sensor strand, a core strand, and a guide strand, which crossover to form a sensor duplex and a RNAi duplex attached to each other to form a single structure. Upon binding an input strand to the sensor strand, the Cond- siRNA is activated and releases RNAi targeting a desired gene.
<P>PROBLEM TO BE SOLVED: To obtain a hydrogen peroxide-containing composition capable of increasing solubility of phenoxyethanol contained therein and capable of improving stability of hydrogen peroxide.  <P>SOLUTION: This hydrogen peroxide-containing composition contains (A) the hydrogen peroxide, (B) the phenoxyethanol, (C) at least one kind of compound selected from 1-hydroxyethane-1,1-disulfonic acid and a salt thereof, (D) a polyhydric alcohol, (E) water, and other components. Both the 1- hydroxyethane-1,1-disulfonic acid and the salt thereof are preferably contained as the component (C). A weight ratio of the contained 1-hydroxyethane-1,1- disulfonic acid to the contained salt thereof is preferably in a range of 1:1 to 2:1. Further, glycols are preferably contained as the component (D). The hydrogen peroxide-containing composition is used as a hair dye, a hair bleaching/decoloring agent, or the like, and can bleach melanin in the hair.  <P>COPYRIGHT: (C)2004,JPO